Dynamic tensiometry studies on interactions of novel therapeutic inhalable powders with model pulmonary surfactant at the air-water interface

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 480, Issue , 2015, Pages 149-158

  Kramek Romanowska, Katarzyna ^a   Odziomek, Marcin ^a   Sosnowski, Tomasz R ^a  

^a WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Bubble pressure tensiometry; Dynamic surface tension; Inhalation; Powder; Pulmonary surfactant

Indexed keywords

AIR; DRUG DELIVERY; DRUG PRODUCTS; PHOSPHOLIPIDS; POWDERS; PRODUCT DESIGN; SURFACE ACTIVE AGENTS; SURFACE TENSION;

DYNAMIC SURFACE TENSIONS; INHALATION; MAXIMUM BUBBLE PRESSURE; MULTIFUNCTIONAL COMPOSITES; PHARMACEUTICAL PRODUCTS; PULMONARY SURFACTANTS; TENSIOMETRY; THERAPEUTIC INTERVENTION;

PHASE INTERFACES;

ACETYLCYSTEINE; BERACTANT; CROMOGLYCATE DISODIUM; DEXTRAN; LUNG SURFACTANT; MANNITOL; WATER;

ADSORPTION KINETICS; AEROSOL; AIR; ARTICLE; BREATHING; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CHEMICAL INTERACTION; CHEMICAL PARAMETERS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DYNAMICS; MAXIMUM BUBBLE PRESSURE TENSIOMETRY; PHYSICAL CHEMISTRY; POWDER; PRIORITY JOURNAL; SPRAY DRYING; SURFACE TENSION;

EID: 84939417935     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2015.02.017     Document Type: Article

References (65)

1. Daniher D.I., Zhu J. Dry powder platform for pulmonary drug delivery. Particuology 2008, 6:225-238.
2. Finlay W.H., Martin A.R. Recent advances in predictive understanding of respiratory tract deposition. J. Aerosol Med. Pulm. Drug. Deliv. 2008, 21(2):189-206.
3. Carvalho T.C., Peters J.I., Williams O.R. Influence of particle size on regional lung deposition-what evidence is there?. Int. J. Pharm. 2011, 406(1-2):1-10.
4. Darquenne C. Aerosol deposition in health and disease. J. Aerosol Med. Pulm. Drug. Deliv. 2012, 25(3):140-147.
5. Howarth P.H. Why particle size should affect clinical response to inhaled therapy. J. Aerosol Med. 2001, 14(Suppl. 1):S27-S34.
6. Odziomek M., Sosnowski T.R., Gradoń L. Conception, preparation and properties of functional carrier particles for pulmonary drug delivery. Int. J. Pharm. 2012, 433:51-59.
7. Patton J.S. Mechanisms of macromolecule absorption by the lungs. Adv. Drug Deliv. Rev. 1996, 19:3-36.
8. Schneeberger E.E. Structural basis for some permeability properties of the air-blood barrier. Fed. Proc. 1978, 37:2471-2478.
9. Barnes P.J. Distribution of receptor targets in the lung. Proc. Am. Thor. Soc. 2004, 1:345-351.
10. Kim C.S., Mungen A.E., Eldridge A., Wanner A. Airway responsiveness to inhaled and intravenous carbachol in sheep: effect of airway mucus. J. Appl. Physiol. 1988, 65:2744-2751.
11. King M., Kelly S., Costo M. Alternation of airway reactivity by mucus. Respir. Physiol. 1985, 62:47-59.
12. Ferrari S., Kitson C., Farley R., Steel R., Marriot C., Parkins D.A., Scarpa M., Wainwright B., Evans M.J., Coledge W.H., Geddes D.M., Alton M. Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium. Gene Ther. 2001, 8:1380-1386.
13. Stern M., Caplen N.J., Browning J.E., Griesenbach U., Sorgi F., Huang L., Gruenert D.C., Marriot C., Crystal R.G., Geddes M.G., Alton E.W. The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro. Gene Ther. 1998, 5:91-98.
14. L. Gradoń, T.R. Sosnowski, M. Pirozyński, Composite carrier for powdery drugs, a method of the carrier manufacturing and a plant for manufacturing the composite carrier particles, Patent Application WO 2009131473 A2 (2009).
15. Sosnowski T.R., Gradoń L. Modification of inhalable powders by pulmonary surfactant componentsadsorbed on droplets during spray-drying process. Colloids Surf. A: Physicochem. Eng. Aspects 2010, 365:56-61.
16. Kaialy W., Momin M.N., Ticehurst M.D., Murphy J., Nokhodchi A. Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler. Colloids Surf. B: Biointerfaces 2010, 79:345-356.
17. D.T. Vodak, D.E. Dobry, D. Friesen, M. Reed, A.P. Gigliotti, P. Kuehl, D.K. Lyon, Dextran-based materials as excipients in engineered particle formulations: tailoring physical properties to optimize performance. Manufacturability and safety., in: R.N. Dalby, P.R., Byron, J., Peart, J.D., Suman, P.M. Young (Eds.), RDD Europe 2011, Virginia Commonwealth University, Richmond, 2011, pp. 125-134.
18. Matsuyama T., Morita T., Horikiri Y., Yamahara H., Yoshino H. Enhancement of nasal absorption of large molecular weight compounds by combination of mucolytic agent and nonionic surfactant. J. Control. Release 2006, 110:347-352.
19. Takatsuka S., Morita T., Horikiri Y., Yamahara H., Saji H. Influence of various combinations of mucolytic agent and non-ionic surfactant on intestinal absorption of poorly absorbed hydrophilic compounds. Int. J. Pharm. 2008, 349:94-100.
20. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim. Biophys. Acta 1998, 1408:79-89.
21. Enhorning G., Duffy L.C., Welliver R.C. Pulmonary surfactant maintains patency of conducting airways in the rat. Am. J. Respir. Crit. Care Med. 1995, 151:554-556.
22. Hohlfeld J., Fabel H., Hamm H. The role of pulmonary surfactant in obstructive airways disease. Eur. Respir. J. 1997, 10:482-491.
23. Zuo Y.Y., Veldhuizen R.A.W., Neumann A.W., Petersen N.O., Possmayer F. Current perspectives in pulmonary surfactnat-Inhibition, enhancement and evaluation. Biochim. Biophys. Acta 2008, 1778:1947-1977.
24. Zuo Y.Y., Ding M., Bateni A., Hoorfar M., Neumann A.W. Improvement of interfacial tension measurement using a captive bubble in conjunction with axisymmetric drop shape analysis (ADSA). Colloids Surf. A: Physicochem. Eng. Aspects 2004, 250:233-246.
25. Mysels K. The maximum bubble pressure method of measuring surface tension revisited. Coll. Surf. 1990, 43:241-262.
26. Kovalchuck V., Dukhin S., Makievski A., Fainerman V., Miller R. Simultaneous calculation of lifetime and deadtime in the maximum bubble pressure measurements. J. Coll. Interf. Sci. 1998, 198:191-200.
27. T. Miller, W. Meyer, Method for the measurement of dynamic surface tension, Am. Lab. 91-97 (1984) February.
28. Adamson A. The Physical Chemistry of Surfaces 1991, New York, Wiley. fifth ed.
29. Kazakov V.N., Sinyachenko O.V., Fainerman V.B., Pison U., Miller R. Dynamic Surface Tensiometry in Medicine 2000, Elsevier, Amsterdam.
30. Kazakov V.N., Vozianov A.F., Sinyachenko O.V., Trukhin D.V., Kovalchuk V.I., Pison U. Studies on the application of dynamic surface tensiometry of serum and cerebrospinal liquid for diagnostics and monitoring of treatment in patients who have rheumatic, neurological or oncological diseases. Adv. Colloid Interface Sci. 2000, 86:1-38.
31. Kazakov V.N., Fainerman V.B., Kondratenko P.G., Elin A.F., Sinyachenko O.V., Miller R. Dilational rheology of serum albumin and blood serum solutions as studied by oscillating drop tensiometry. Colloids Surf. B: Biointerfaces 2008, 62:77-82.
32. Kazakov V.N., Udod A.A., Zinkovych I.I., Fainerman V.B., Miller R. Dynamic surface tension of saliva: General relationships and application in medical diagnostics. Colloids Surf. B: Biointerfaces 2009, 74:457-461.
33. Notter R.H., Wang Z., Egan E.A., Holm B.A. Component-specific surface and physiological activity in bovine-derived lung surfactants. Chem. Phys. Lip. 2002, 114:21-34.
34. Kondej D., Sosnowski T.R. Alteration of biophysical activity of pulmonary surfactant by aluminosilicate nanoparticles. Inhal. Toxicol. 2013, 25:77-83.
35. Kramek-Romanowska K., Odziomek M., Sosnowski T.R., Gradoń L. Effects of process variables on the properties of spray-dried mannitol and mannitol/disodium cromoglycate powders suitable for drug delivery by inhalation. Ind. Eng. Chem. Res. 2011, 50:13922-13931.
36. Gregoratto D., Bailey M.R., Marsh J.W. Modelling particle retention in the alveolar-interstitial region of the human lungs. J. Radiol. Prot. 2010, 30:491-512.
37. Fainerman V.B., Makievski A.V., Miller R. The analysis of dynamic surface tension of sodium alkyl sulphate solutions, based on asymptotic equations of adsorption kinetic theory. Colloids Surf. 1994, 87:61-75.
38. Miller R., Joos P., Fainerman V.B. Dynamic surface and interfacial tensions of surfactant and polymer solutions. Adv. Colloid Interface Sci. 1994, 49:249-302.
39. Li J., Fainerman V.B., Miller R. Adsorption kinetics of phospholipids at the chloroform/water interface studied by drop volume and pendant drop techniques. Langmuir 1996, 12:5138-5142.
40. Ward A.F.H., Tordai L. Time-dependence of boundary tensions of solutions I. The role of diffusion in time-effects. J. Chem. Phys. 1946, 14:453-461.
41. Saad S.M.I., Neumann A.W., Acosta E.J. A dynamic compression-relaxation model for lung surfactants. Colloids Surf. A: Physicochem. Eng. Aspects 2010, 354:34-44.
42. Kazakov V.N., Sinyachenko O.V., Trukhin D.V., Pison U. Dynamic interfacial tensiometry of biologic liquids-does it have an impact on medicine. Colloids Surf. A: Physicochem. Eng. Aspects 1998, 143:441-459.
43. Rillaerts E., Joos P. Rate of demicellization from the dynamic surface tensions of micellar solutions. J. Phys. Chem. 1982, 86:3471-3478.
44. Ampatzidis C.D., Varka E-M.A., Karapantsios T.D. Dynamic surface properties of eco-friendly phenylalanine glycerol ether surfactants at the W/A interface. Colloids Surf. A: Physicochem. Eng. Aspects 2014, 441:872-879.
45. Pison U., Herold R., Schürch S. The pulmonary surfactant system: biological functions, components, physicochemical properties and alterations during lung disease. Colloids Surf. A: Physicochem. Eng. Aspects 1996, 114:165-184.
46. Holm B.A., Notter R.H., Finkelstein J.N. Surface property changes from interactions of albumin with natural surfactant and extracted lung surfactant lipids. Chem. Phys. Lipids 1985, 38:287-298.
47. Holm B.A., Venkitaraman A.R., Enhorning G., Notter R.H. Biophysical inhibition of synthetic lung surfactants. Chem. Phys. Lipids 1990, 52:243-250.
48. Notter R.H. Lung Surfactant. Basic Science and Clinical Applications 2000, Marcel Dekker Inc, New York.
49. Rodriguez-Capote K., Manzanares D., Haines T., Possmayer F. Reactive oxygen species inactivation of surfactant involves structural and functional alterations to surfactant proteins Sp-B and SP-C. Biophys. J. 2006, 90:2808-2821.
50. Bringezu F., Pinkerton K.E., Zasadzinski J.A. Environmental tobacco smoke effects on the primary lipids of lung surfactant. Langmuir 2003, 19:2900-2907.
51. Hall S.B., Lu R.Z., Venkitaraman A.R., Hyde R.W., Notter R.H. Inhibition of pulmonary surfactant by oleic acid: mechanisms and characteristics. J. Appl. Physiol. 1992, 72:1708-1716.
52. Holm B.A., Enhorning G., Notter R.H. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem. Phys. Lipids 1988, 49:49-55.
53. Comroe J.H. Premature science and immature lungs. Part II. Chemical warfare and the newly born. Am. Rev. Respir. Dis. 1977, 116:311-323.
54. Saenz A., Casals C. Mechanisms involved in surfactant inhibition by CRP: the protective role of SP-A. Eur. Biophys. J. 2007, 36(Suppl. 1):S85.
55. Kobayashi T., Shido A., Nitta K., Inui S., Ganzuka M., Robertson B. The critical concentration of surfactant in fetal lung liquid at birth. Respir Physiol. 1990, 80(2-3):181-192.
56. Park S.Y., Hannemann R.E., Franses E.I. Dynamic tension and adsorption behavior of aqueous lung surfactants. Colloids Surf. B: Biointerfaces 1999, 15:325-338.
57. Kondej D., Sosnowski T.R. Changes in the activity of the pulmonary surfactant after contact with bentonite nanoclay particles. Chem. Eng. Transact. 2012, 26:531-536.
58. Fainerman V.B., Miller R. Adsorption kinetics of short-chain alcohols at the water/air interface: diffusion-controlled adsorption under the conditions of a nonequilibrium surface layer. J. Colloid Interface Sci. 1996, 178:168-175.
59. Joos P., Serrien G. Adsorption kinetics of lower alkanols at the air/water interface: Effect of structure makers and structure breakers. J. Colloid Interface Sci. 1989, 127:97-103.
60. Kobayashi T., Ohta K., Tashiro K., Nishizuka K., Chen W.M., Ohmura S., Yamamoto K. Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract. J. Appl. Physiol. 1999, 86:1778-1784.
61. Lu K.W., Robertson B., Taeusch H.W. Dextran or polyethylene glycol added to curosurf for treament of meconium lung injury in rats. Biol. Neonate 2005, 88:46-53.
62. Calkovska A., Some M., Linderholm B., Curstedt T., Robertson B. Therapeutic effects of exogenous surfactant enriched with dextran in newborn rabbits with respiratory failure induced by airway instillation of albumin. Pulm. Pharmacol. Ther. 2008, 21:393-400.
63. Putz G., Goerke J., Taeusch H.W., Clements J.A. Comparison of captive and pulsating bubble surfactometers with use of lung surfactant. J. Appl. Physiol. 1994, 76:1425-1431.
64. Schurch S., Bachofen H., Goerke J., Possmayer F. A captive bubble method reproduces the in situ behavior of lung surfactant monolayers. J. Appl. Physiol. 1989, 67:2389-2396.
65. Schoel W.M., Schurch S., Goerke J. The captive bubble method for the evaluation of pulmonary surfactant: surface tension, area and volume calculations. Biochim. Biophys. Acta 1994, 1200:281-290.